scholarly journals Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Sun-Gyun Kim ◽  
Suho Lee ◽  
Yangsik Kim ◽  
Jieun Park ◽  
Doyeon Woo ◽  
...  

AbstractmTOR signaling, involving mTORC1 and mTORC2 complexes, critically regulates neural development and is implicated in various brain disorders. However, we do not fully understand all of the upstream signaling components that can regulate mTOR signaling, especially in neurons. Here, we show a direct, regulated inhibition of mTOR by Tanc2, an adaptor/scaffolding protein with strong neurodevelopmental and psychiatric implications. While Tanc2-null mice show embryonic lethality, Tanc2-haploinsufficient mice survive but display mTORC1/2 hyperactivity accompanying synaptic and behavioral deficits reversed by mTOR-inhibiting rapamycin. Tanc2 interacts with and inhibits mTOR, which is suppressed by mTOR-activating serum or ketamine, a fast-acting antidepressant. Tanc2 and Deptor, also known to inhibit mTORC1/2 minimally affecting neurodevelopment, distinctly inhibit mTOR in early- and late-stage neurons. Lastly, Tanc2 inhibits mTORC1/2 in human neural progenitor cells and neurons. In summary, our findings show that Tanc2 is a mTORC1/2 inhibitor affecting neurodevelopment.

2020 ◽  
Author(s):  
Sun-Gyun Kim ◽  
Suho Lee ◽  
Yangsik Kim ◽  
Ji Eun Park ◽  
Doyeon Woo ◽  
...  

Abstract mTOR signaling, involving mTORC1 and mTORC2 complexes, critically regulates neural development and is implicated in various brain disorders. mTORC1/2 components that stimulate mTOR kinase activity strongly affect neurodevelopment, but mTOR-inhibitory mTORC1/2 components do not, questioning the role of balanced mTOR regulation in neurodevelopment. We found a direct, regulated inhibition of mTOR by Tanc2, an adaptor/scaffolding protein with strong neurodevelopmental and psychiatric implications. While Tanc2-null mice show embryonic lethality, Tanc2-haploinsufficient mice survive but display mTORC1/2 hyperactivity accompanying synaptic and behavioral deficits reversed by mTOR-inhibiting rapamycin. Tanc2 directly interacts with and inhibits mTOR, which is suppressed by mTOR-activating serum or ketamine, a fast-acting antidepressant. Tanc2 and Deptor, known to inhibit mTORC1/2 but minimally affect neurodevelopment, distinctly inhibit mTOR in early- and late-stage neurons. Patient-derived Tanc2 mutations disable Tanc2 function, and human Tanc2 inhibits mTORC1/2. Therefore, Tanc2 represents a novel mTORC1/2 inhibitor with strong neurodevelopmental impacts, implicating mTOR inhibition in treating TANC2-related brain disorders and Tanc2 modulation in treating mTOR-related disorders.


2014 ◽  
Vol 212 (1) ◽  
pp. 73-91 ◽  
Author(s):  
Chider Chen ◽  
Kentaro Akiyama ◽  
Dandan Wang ◽  
Xingtian Xu ◽  
Bei Li ◽  
...  

Fibrillin-1 (FBN1) deficiency-induced systemic sclerosis is attributed to elevation of interleukin-4 (IL4) and TGF-β, but the mechanism underlying FBN1 deficiency–associated osteopenia is not fully understood. We show that bone marrow mesenchymal stem cells (BMMSCs) from FBN1-deficient (Fbn1+/−) mice exhibit decreased osteogenic differentiation and increased adipogenic differentiation. Mechanistically, this lineage alteration is regulated by IL4/IL4Rα-mediated activation of mTOR signaling to down-regulate RUNX2 and up-regulate PPARγ2, respectively, via P70 ribosomal S6 protein kinase (P70S6K). Additionally, we reveal that activation of TGF-β/SMAD3/SP1 signaling results in enhancement of SP1 binding to the IL4Rα promoter to synergistically activate mTOR pathway in Fbn1+/− BMMSCs. Blockage of mTOR signaling by osteoblastic-specific knockout or rapamycin treatment rescues osteopenia phenotype in Fbn1+/− mice by improving osteogenic differentiation of BMMSCs. Collectively, this study identifies a previously unrecognized role of the FBN1/TGF-β/IL4Rα/mTOR cascade in BMMSC lineage selection and provides experimental evidence that rapamycin treatment may provide an anabolic therapy for osteopenia in Fbn1+/− mice.


PLoS ONE ◽  
2009 ◽  
Vol 4 (10) ◽  
pp. e7630 ◽  
Author(s):  
Dhruv Sareen ◽  
Erin McMillan ◽  
Allison D. Ebert ◽  
Brandon C. Shelley ◽  
Julie A. Johnson ◽  
...  

2016 ◽  
Vol 65 ◽  
pp. 212-223 ◽  
Author(s):  
Hee Yeon Kim ◽  
Susanna H. Wegner ◽  
Kirk P. Van Ness ◽  
Julie Juyoung Park ◽  
Sara E. Pacheco ◽  
...  

2019 ◽  
Vol 12 (1) ◽  
pp. 4-16 ◽  
Author(s):  
Kushani Shah ◽  
Gwendalyn D King ◽  
Hao Jiang

Abstract It remains unknown whether H3K4 methylation, an epigenetic modification associated with gene activation, regulates fate determination of the postnatal neural stem and progenitor cells (NSPCs). By inactivating the Dpy30 subunit of the major H3K4 methyltransferase complexes in specific regions of mouse brain, we demonstrate a crucial role of efficient H3K4 methylation in maintaining both the self-renewal and differentiation capacity of postnatal NSPCs. Dpy30 deficiency disrupts development of hippocampus and especially the dentate gyrus and subventricular zone, the major regions for postnatal NSC activities. Dpy30 is indispensable for sustaining the self-renewal and proliferation of NSPCs in a cell-intrinsic manner and also enables the differentiation of mouse and human neural progenitor cells to neuronal and glial lineages. Dpy30 directly regulates H3K4 methylation and the induction of several genes critical in neurogenesis. These findings link a prominent epigenetic mechanism of gene expression to the fundamental properties of NSPCs and may have implications in neurodevelopmental disorders.


2019 ◽  
Vol 132 (7) ◽  
pp. 805-810
Author(s):  
Jing-Wei Lyu ◽  
Xue-Bi Xu ◽  
Kun-Qian Ji ◽  
Na Zhang ◽  
Yuan Sun ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document